You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API nystatin and triamcinolone acetonide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing nystatin and triamcinolone acetonide

Company Ingredient NDC Excipient
E Fougera & Co a division of Fougera Pharmaceuticals Inc nystatin and triamcinolone acetonide 0168-0081 ALGELDRATE
E Fougera & Co a division of Fougera Pharmaceuticals Inc nystatin and triamcinolone acetonide 0168-0081 BENZYL ALCOHOL
E Fougera & Co a division of Fougera Pharmaceuticals Inc nystatin and triamcinolone acetonide 0168-0081 CETOSTEARYL ALCOHOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for nystatin and triamcinolone acetonide

Excipient focus: ALGELDRATE

Excipient focus: ALUMINUM HYDROXIDE

Excipient focus: BENZYL ALCOHOL

Excipient focus: CETEARETH-15

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: CETYL PALMITATE

Excipient focus: DIMETHICONE

Excipient focus: GLYCERYL MONO AND DIPALMITOSTEARATE

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HIGH DENSITY POLYETHYLENE

Excipient focus: LOW DENSITY POLYETHYLENE

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYLPARABEN

Excipient focus: MINERAL OIL

Excipient focus: PEG-8 STEARATE

Excipient focus: PETROLATUM

Excipient focus: POLAWAX POLYSORBATE

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER

Excipient focus: POLYOXYL 8 STEARATE

Excipient focus: POLYSORBATE 60

Excipient focus: POTASSIUM SORBATE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SORBIC ACID

Excipient focus: SORBITOL

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group